Cargando…
Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649690/ https://www.ncbi.nlm.nih.gov/pubmed/31360869 http://dx.doi.org/10.1093/jncics/pky039 |
| _version_ | 1783438035435651072 |
|---|---|
| author | Moon, Dominic H Chen, Ronald C |
| author_facet | Moon, Dominic H Chen, Ronald C |
| author_sort | Moon, Dominic H |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6649690 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66496902019-07-29 Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society Moon, Dominic H Chen, Ronald C JNCI Cancer Spectr Editorial Oxford University Press 2018-11-27 /pmc/articles/PMC6649690/ /pubmed/31360869 http://dx.doi.org/10.1093/jncics/pky039 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Editorial Moon, Dominic H Chen, Ronald C Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title | Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title_full | Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title_fullStr | Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title_full_unstemmed | Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title_short | Defining a Clinically Meaningful Benefit in Cancer Clinical Trials: From the Perspectives of the Clinical Trialist, Patient, and Society |
| title_sort | defining a clinically meaningful benefit in cancer clinical trials: from the perspectives of the clinical trialist, patient, and society |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649690/ https://www.ncbi.nlm.nih.gov/pubmed/31360869 http://dx.doi.org/10.1093/jncics/pky039 |
| work_keys_str_mv | AT moondominich definingaclinicallymeaningfulbenefitincancerclinicaltrialsfromtheperspectivesoftheclinicaltrialistpatientandsociety AT chenronaldc definingaclinicallymeaningfulbenefitincancerclinicaltrialsfromtheperspectivesoftheclinicaltrialistpatientandsociety |